ARTICLE | Company News
Celtic acquires NTII's Xerecept
September 21, 2005 1:06 AM UTC
Celtic (Hamilton, Bermuda) acquired exclusive worldwide rights to Xerecept corticotropin-releasing factor from Neurobiological Technologies (NTII). The synthetic human corticotropin-releasing factor (...